Clinical Trial Update: RElevance of Biomarkers for Future Risk of Thromboembolic Events in UnSelected Post-myocardial Infarction Patients

View source ↗

Summary

A completed clinical trial evaluating the relevance of biomarkers to predict future thromboembolic events in unselected patients after myocardial infarction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Snippet

Sponsor: Uppsala University | Conditions: Myocardial Infarction | Status: COMPLETED